CClinicalTrials.gg
CompletedNCT03656887HAGEDUpdated Feb 4, 2026

Screening for Hypoglycemia in an Institutionalized Elderly Diabetic Population.

An observational study in Old Age, Institutionalized in EHPAD (French Nursing Home) and Diabetes, sponsored by Centre Hospitalier Universitaire Dijon. Completed at 1 site in France. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-02-04.

Sponsored by Centre Hospitalier Universitaire Dijon · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
29
Ages
60 Years and older
Sex
All
01

Study summary

Diabetes is a major public health problem that has been growing steadily in recent years. Its prevalence is very high in the elderly, in whom there is an increased risk of hypoglycemia.

Hypoglycaemia in elderly diabetics has serious consequences:

  • increased mortality,
  • increased cardiovascular morbidity,
  • increased risk of falling,
  • impairment of quality of life.
  • Hypoglycaemia is also a risk factor for dementia in type 2 diabetes. The frequency of asymptomatic and atypical hypoglycemia has been shown to be greater in the elderly, but the exact prevalence of hypoglycemia in the elderly remains unknown.

Elderly diabetic patients in institutions are particularly fragile and have more frequent cognitive problems than non-diabetic subjects. A study conducted in this population of patients showed that a third of them had HbA1C \<6.5%, which suggests a higher frequency of hypoglycemia though the figures were not available.

We therefore decided to conduct a study to assess the frequency of hypoglycemia in order to better understand the contributing factors and to improve the management of this fragile population.

02

Conditions studied

  • Old Age
  • Institutionalized in EHPAD (French Nursing Home)
  • Diabetes
  • Hypoglycemic Syndrome
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 29 is below the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Centre Hospitalier Universitaire Dijon is the lead sponsor of 495 studies on the registry; 105 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient institutionalized in EHPAD

Inclusion criteria

  • written consent
  • diabetic patient receiving treatment which could result in hypoglycemia: insulin and/or sulfonamide and/or glinides
  • institutionalized patient in an EHPAD
  • patient over 60 years of age

Exclusion criteria

Exclusion Criteria:

- person not affiliated to a national health insurance

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
29 participants (actual)
Patient registry
No

Interventions

  • DeviceContinuous interstitial glucose sensor

    Installing and removing the sensor

  • OtherSensor Scan

    Scan of the sensor, using the Freestyle Pro free version reader, at installation then before removal after 14 days.

06

What researchers measure

Primary outcomes

  1. Number of hypoglycemic events (<70 mg/dl) demonstrated by continuous interstitial glucose monitoring over the study period.

    Time frame: Day 14

  2. Number of hypoglycemic events (<70 mg/dl) detected by capillary blood glucose measurement or clinical signs suggestive of hypoglycemia.

    Time frame: Day 14

07

Study locations

1 site
  • Chu Dijon Bourogne
    Dijon, 21000, France
08

References and documents

Publications

  • Bouillet B, Tscherter P, Vaillard L, Nonciaux C, Hourdain P, Ravier A, Rouland A, Petit JM, Verges B, Quilot E. Frequent and severe hypoglycaemia detected with continuous glucose monitoring in older institutionalised patients with diabetes. Age Ageing. 2021 Nov 10;50(6):2088-2093. doi: 10.1093/ageing/afab128. PubMed 34324624 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03656887
Lead sponsor
Centre Hospitalier Universitaire Dijon
Responsible party
Sponsor
First posted
Sep 4, 2018
Start date
Jan 8, 2019
Primary completion
Jun 11, 2019
Completion
Jun 11, 2019
Last update
Feb 4, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion